Cancer Trials Ireland opens new breast cancer trial

Cancer Trials Ireland has today (Monday, 27 June 2016) announced that it has opened a cancer trial to test a new treatment for patients with advanced breast cancer which has not responded to currently available treatments.

The trial will test for the first time the use of the new drug copanlisib in combination with trastuzumab to treat advanced HER2-positive (HER2+) breast cancer which has progressed or recurred in patients during or following standard anti-HER2 treatment.

It is expected that up 34 patients will take part in the trial which will be conducted over the next 2-3 years in Beaumont Hospital in Dublin, St Vincent’s University Hospital in Dublin, St. James’s Hospital in Dublin, University Hospital Galway and Cork University Hospital at a cost of approximately 750,000 euro.



Summer DSSG Digest available here

The Summer DSSG Digest contains a full digest of all our cancer trials that are currently open.

Please click here to download.

Irish research in world’s largest oncology meeting



65 abstracts that include Irish Cancer Researchers have been included in The American Society of Clinical Oncology (ASCO) 2016 Annual Meeting which occurs in Chicago on June 3-7.

Clinical Trials Day 2016

Happy International Clinical Trials Day

Here’s a brief video which will give you a flavour of yesterday’s International Clinical Trials Day Launch at the Mansion House in Dublin. 

A huge thanks to all who made it all possible.